Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By



Set Alert for Vaccines

Pirbright study establishes PPR vaccination cost framework

A study led by the UK's Pirbright Institute has established the first framework for determining the real cost of peste des petits ruminants (PPR) vaccination campaigns.

Research Vaccines

Animal Pharm Awards presents accolades to serial winners and new names

Zoetis, Merck Animal Health and Biogénesis Bagó have all won Animal Pharm Awards in 2018 – adding to their accolades from previous years.

Biogenesis Bago Kindred Biosciences

Pirbright shares CRISPR methods for developing poultry diseases vaccine

The Pirbright Institute has revealed new methods for creating a vaccine against Marek's disease and infectious bursal disease (IBD) using CRISPR/CAS9 gene editing.

Vaccines Research

Merck signs equine vaccine development deal with Alopexx

Merck Animal Health has signed an exclusive global license agreement with US firm Alopexx Vaccine. 

Merck MSD Animal Health Deals

Vietnam starts increasing investment on local FMD vaccines

Foot-and-mouth disease (FMD) has been rampant in Vietnam and has triggered severe hardship and economic losses for the country's cattle farmers for years. Animal Pharm correspondent Mainbayar Badarch explores how Vietnam has gone about tackling the disease.

Foot and mouth disease Vaccines

Bioveta secures more double-digit growth through vaccine sales

Czech Republic-based Bioveta maintained its recent double-digit sales growth into fiscal 2018.

Financial Results Vaccines

Elanco applies for patent covering new BRD vaccine

Elanco and Zoetis are among the animal health companies to make recent patent applications in the field of bovine health.

R&D Elanco

BunyaVax closes in on efficacy data, series A round

Dutch start-up BunyaVax aims to secure positive study results and series A funding in 2019.

Vaccines R&D

VIDO-InterVac appoints new director and CEO

Volker Gerdts has been selected to lead the University of Saskatchewan's Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac).

People Vaccines

Review 2018: Smart M&A money is put on diagnostics and digital tech

In 2018, the stand-out M&A deals targeted diagnostics, digital technologies and nutrition. While Zoetis and Merck Animal Health made multi-billion-dollar deals, some of the sector's smaller purchases also hinted towards important trends. Animal Pharm editor Joseph Harvey looks back at where the money was spent.

M&A Abaxis

MSD secures first fully-owned Chinese vaccine facility with Zhejiang acquisition

MSD Animal Health's has purchased Zhejiang ZhengliAntoo Biotech – a privately owned veterinary vaccine specialist based in China – for an undisclosed fee.

Merck MSD Animal Health China

AniCon takes diagnostic products and custom vaccines expertise to wider European markets

German firm AniCon Labor is increasing its sales base for its veterinary diagnostic products and autogenous vaccines outside its domestic market.

Diagnostics Vaccines
See All